On April 12th, the 25th International Ophthalmology Academic Conference and the 25th International Optometry Academic Conference (COOC 2025) successfully concluded at the Shanghai International Procurement Exhibition Center. During the conference, China's leading high-end ophthalmic equipment company Yaoshi Medical brought its star product "Yaoxinghai" Yetsea100 ultra wide angle SLO, which caused a strong industry shock with its breakthrough technology.
The audience in front of the Yaoshi Medical booth was endless, and the three core technologies of the Yetsea100 ultra wide angle SLO from Yaoxinghai became the focus of the entire event.
1. One click fully automatic, easy to handle ultra wide angle fundus examination
The Yetsea100 ultra wide angle SLO from 'Yaoxinghai' integrates advanced autofocus, precise positioning, and fast scanning technology. With just one click, the entire examination process can be automatically completed, completely overturning the tedious manual debugging process in traditional fundus examinations. This not only greatly improves the efficiency of the examination, but also reduces the workload of medical staff, ensuring that each examination can be completed in the shortest possible time, bringing a more comfortable experience to the examination.
According to a survey conducted among users on the automatic scanning of the "Yaoxinghai" Yetsea100 ultra wide angle SLO, over 90% of them believe that compared to traditional manual devices, the "Yaoxinghai" Yetsea100 ultra wide angle SLO significantly reduces the time required for inspection, has a shorter learning curve, and is extremely easy to use.
The Yetsea100 ultra wide angle SLO of 'Yaoxinghai' integrates four wavelengths of laser confocal technology for the first time in China. By precisely controlling the scanning paths of the four laser beams, it achieves precise capture of different depths of the fundus. Compared to traditional imaging techniques, four laser confocal imaging has higher resolution and deeper imaging depth, which can clearly present the details of various layers of the fundus structure.
The Yetsea100 ultra wide angle SLO of 'Yaoxinghai' adopts advanced ultra wide angle imaging technology, and its field of view reaches an unprecedented 168 degrees. Compared to traditional ophthalmoscopes, ultra wide angle vision can capture more details of the fundus at once, which is of great significance for detecting peripheral retinal lesions, microvascular abnormalities, and so on. Doctors can observe the structure of the fundus more comprehensively and meticulously, thereby improving the accuracy and efficiency of diagnosis.
Since the debut of CCOS in 2024, Yaoshi Medical has received widespread attention from the industry. At this conference, colleagues from all walks of life in ophthalmology came one after another, and after experiencing it, they praised the performance of the Yetsea100 ultra wide angle SLO in 'Yaoxinghai'. They highly recognized the product's ultra wide angle imaging range, excellent image quality, and color comparable to real colors.
"Ten years ago, we relied on imported equipment; Today, Yaoshi Medical shows us the true strength of China's innovation. " The doctor who experienced the Yetsea100 ultra wide angle SLO of 'Yaoxinghai' said.
With the conclusion of the COOC meeting, the technology craze sparked by the Yetsea100 ultra wide angle SLO from 'Yaoxinghai' continues. This ophthalmic imaging system, which embodies Chinese wisdom, may usher in a new era of precision ophthalmic diagnosis and treatment.
About Guoqian
Guoqian Medical Technology (Suzhou) Co., Ltd. is jointly invested and established by Dr. Zhang Xu and seven other national major talent engineering experts who have successfully innovated and started businesses in the fields of biomedical and medical devices, as well as shareholders in other fields.
Guoqian Medical is committed to investing in medical device innovation technology industry, entrepreneurial incubation, and precise empowerment. Guoqian Venture Capital Management (Suzhou) Co., Ltd., a wholly-owned subsidiary, is a venture capital firm specializing in early-stage equity investment in medical devices. Adhering to the business philosophy of "achieving others' dreams", Guoqian Venture Capital invests and aggregates industries through its managed equity investment funds, while Guoqian Medical creates an industrial ecosystem through incubation and empowerment. The two business platforms are highly coordinated, creating a high-end medical equipment industry cluster and ecosystem in Suzhou High tech Zone.